3-hydroxybutyric acid has been researched along with Fatty Liver in 53 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two experiments were conducted to evaluate if supplementing rumen-protected choline (RPC; Reashure, Balchem Encapsulates, Slate Hill, NY) could prevent or alleviate fatty liver in dairy cattle." | 9.12 | Supplemental choline for prevention and alleviation of fatty liver in dairy cattle. ( Bertics, SJ; Caraviello, DZ; Cooke, RF; Grummer, RR; Ramos, MH; Silva Del Río, N, 2007) |
| "To test glucagon as a treatment for fatty liver, either glucagon at 10 mg/d or excipient was infused via the jugular vein from 21 to 35 d postpartum." | 5.30 | Alleviation of fatty liver in dairy cows with 14-day intravenous infusions of glucagon. ( Beitz, DC; Hippen, AR; Lindberg, GL; Richardson, LF; She, P; Tucker, RW; Young, JW, 1999) |
| "The human fatty liver takes up 2-arachidonoylglycerol and overproduces triacylglycerols containing saturated fatty acids, which might reflect increased de novo lipogenesis." | 5.14 | Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. ( Arola, J; Castillo, S; Fielding, BA; Frayn, KN; Hodson, L; Hultcrantz, R; Kotronen, A; Olkkonen, VM; Orešič, M; Perttilä, J; Seppänen-Laakso, T; Suortti, T; Wahren, J; Westerbacka, J; Yki-Järvinen, H, 2010) |
| "Two experiments were conducted to evaluate if supplementing rumen-protected choline (RPC; Reashure, Balchem Encapsulates, Slate Hill, NY) could prevent or alleviate fatty liver in dairy cattle." | 5.12 | Supplemental choline for prevention and alleviation of fatty liver in dairy cattle. ( Bertics, SJ; Caraviello, DZ; Cooke, RF; Grummer, RR; Ramos, MH; Silva Del Río, N, 2007) |
| "Clinical investigations suggest that hepatotoxicity after acetaminophen (APAP) overdose could be more severe in the context of obesity and nonalcoholic fatty liver disease." | 3.78 | Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice. ( Aubert, J; Begriche, K; Delannoy, M; Fromenty, B; Jaeschke, H; Lepage, S; Lucas-Clerc, C; McGill, MR; Morel, I; Pajaud, J; Ribault, C; Robin, MA; Turlin, B, 2012) |
| " Metabolic changes (liver steatosis and loss of muscle glycogen stores) appear also early after carnitine deprivation." | 3.74 | Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency. ( Beier, K; Knapp, AC; Krähenbühl, S; Todesco, L; Torok, M, 2008) |
| "Fatty liver is a major metabolic disorder of high-producing dairy cows during the transition period." | 1.91 | Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver. ( Chen, L; Jiang, Q; Kong, F; Lei, L; Li, J; Li, X; Liu, G; Liu, M; Loor, JJ; Wang, X; Zhao, C; Zhu, Y, 2023) |
| "Originally described in diabetic ketoacidosis, renal vacuoles can be found in other ketogenic states such as alcoholic ketoacidosis (AKA), starvation, and hypothermia, underpinned by deranged fatty acid metabolism." | 1.91 | Subnuclear renal tubular vacuoles in alcohol use disorder. ( Auld, FM; Milroy, CM; Parai, JL, 2023) |
| "Fatty liver is a common metabolic disorder in dairy cows during the transition period." | 1.51 | Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly. ( Bucktrout, R; Dong, J; Jia, H; Li, G; Li, X; Liu, G; Loor, JJ; Shu, X; Sun, X; Wang, Y; Wang, Z; Zuo, R, 2019) |
| "To test glucagon as a treatment for fatty liver, either glucagon at 10 mg/d or excipient was infused via the jugular vein from 21 to 35 d postpartum." | 1.30 | Alleviation of fatty liver in dairy cows with 14-day intravenous infusions of glucagon. ( Beitz, DC; Hippen, AR; Lindberg, GL; Richardson, LF; She, P; Tucker, RW; Young, JW, 1999) |
| "Results indicate that experimental ketosis was preceded by metabolic abnormalities up to 2 wk before clinical ketosis occurred." | 1.28 | Metabolic changes in blood and liver during development and early treatment of experimental fatty liver and ketosis in cows. ( Drackley, JK; Miller, LD; Richard, MJ; Sanderson, TP; Veenhuizen, JJ; Young, JW, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.66) | 18.7374 |
| 1990's | 10 (18.87) | 18.2507 |
| 2000's | 19 (35.85) | 29.6817 |
| 2010's | 15 (28.30) | 24.3611 |
| 2020's | 6 (11.32) | 2.80 |
| Authors | Studies |
|---|---|
| Cholico, GN | 1 |
| Orlowska, K | 1 |
| Fling, RR | 1 |
| Sink, WJ | 1 |
| Zacharewski, NA | 1 |
| Fader, KA | 1 |
| Nault, R | 1 |
| Zacharewski, T | 1 |
| Zhu, Y | 2 |
| Lei, L | 1 |
| Wang, X | 2 |
| Jiang, Q | 1 |
| Loor, JJ | 4 |
| Kong, F | 1 |
| Chen, L | 1 |
| Li, J | 1 |
| Zhao, C | 2 |
| Liu, M | 1 |
| Liu, G | 5 |
| Li, X | 8 |
| Auld, FM | 1 |
| Parai, JL | 1 |
| Milroy, CM | 1 |
| Liu, L | 1 |
| Xing, D | 2 |
| Du, X | 2 |
| Peng, T | 1 |
| McFadden, JW | 1 |
| Wen, L | 1 |
| Lei, H | 1 |
| Dong, W | 1 |
| Wang, Z | 3 |
| Su, J | 1 |
| He, J | 1 |
| Nakade, Y | 1 |
| Kitano, R | 1 |
| Yamauchi, T | 1 |
| Kimoto, S | 1 |
| Sakamoto, K | 1 |
| Inoue, T | 1 |
| Kobayashi, Y | 1 |
| Ohashi, T | 1 |
| Sumida, Y | 1 |
| Ito, K | 1 |
| Yoneda, M | 1 |
| McKenzie, AL | 1 |
| Athinarayanan, SJ | 1 |
| McCue, JJ | 1 |
| Adams, RN | 1 |
| Keyes, M | 1 |
| McCarter, JP | 1 |
| Volek, JS | 1 |
| Phinney, SD | 1 |
| Hallberg, SJ | 1 |
| Fang, Z | 1 |
| Bucktrout, R | 2 |
| Yang, Y | 2 |
| Ye, Q | 1 |
| Shi, Z | 1 |
| Shen, T | 1 |
| Peng, Z | 1 |
| Lv, B | 1 |
| Jia, H | 2 |
| Sun, X | 2 |
| Li, G | 1 |
| Shu, X | 2 |
| Dong, J | 2 |
| Wang, Y | 2 |
| Zuo, R | 2 |
| Chen, X | 1 |
| Liang, Y | 1 |
| Malloy, VL | 1 |
| Perrone, CE | 1 |
| Mattocks, DA | 1 |
| Ables, GP | 2 |
| Caliendo, NS | 1 |
| Orentreich, DS | 1 |
| Orentreich, N | 1 |
| Männistö, VT | 1 |
| Simonen, M | 1 |
| Hyysalo, J | 1 |
| Soininen, P | 1 |
| Kangas, AJ | 1 |
| Kaminska, D | 1 |
| Matte, AK | 1 |
| Venesmaa, S | 1 |
| Käkelä, P | 1 |
| Kärjä, V | 1 |
| Arola, J | 2 |
| Gylling, H | 1 |
| Cederberg, H | 1 |
| Kuusisto, J | 1 |
| Laakso, M | 1 |
| Yki-Järvinen, H | 3 |
| Ala-Korpela, M | 1 |
| Pihlajamäki, J | 1 |
| Pawlak, M | 1 |
| Baugé, E | 1 |
| Lalloyer, F | 1 |
| Lefebvre, P | 1 |
| Staels, B | 1 |
| Xiao, Y | 1 |
| Liu, H | 1 |
| Yu, J | 1 |
| Zhao, Z | 1 |
| Xiao, F | 1 |
| Xia, T | 1 |
| Wang, C | 1 |
| Li, K | 1 |
| Deng, J | 1 |
| Guo, Y | 1 |
| Chen, S | 1 |
| Chen, Y | 1 |
| Guo, F | 1 |
| Prodanović, R | 1 |
| Korićanac, G | 1 |
| Vujanac, I | 1 |
| Djordjević, A | 1 |
| Pantelić, M | 1 |
| Romić, S | 1 |
| Stanimirović, Z | 1 |
| Kirovski, D | 1 |
| Dasarathy, S | 2 |
| Kasumov, T | 1 |
| Edmison, JM | 1 |
| Gruca, LL | 1 |
| Bennett, C | 2 |
| Duenas, C | 1 |
| Marczewski, S | 2 |
| McCullough, AJ | 2 |
| Hanson, RW | 1 |
| Kalhan, SC | 2 |
| Kotronen, A | 2 |
| Seppälä-Lindroos, A | 1 |
| Vehkavaara, S | 1 |
| Bergholm, R | 1 |
| Frayn, KN | 3 |
| Fielding, BA | 3 |
| Ghanem, MM | 1 |
| El-Deeb, WM | 1 |
| Westerbacka, J | 1 |
| Wahren, J | 1 |
| Hodson, L | 2 |
| Perttilä, J | 1 |
| Seppänen-Laakso, T | 1 |
| Suortti, T | 1 |
| Hultcrantz, R | 1 |
| Castillo, S | 1 |
| Olkkonen, VM | 1 |
| Orešič, M | 1 |
| McQuaid, SE | 1 |
| Humphreys, SM | 1 |
| Milne, R | 1 |
| Karpe, F | 1 |
| Osman, MA | 1 |
| Allen, PS | 1 |
| Bobe, G | 1 |
| Coetzee, JF | 1 |
| Abuzaid, A | 1 |
| Koehler, K | 1 |
| Beitz, DC | 2 |
| Kalaitzakis, E | 1 |
| Panousis, N | 1 |
| Roubies, N | 1 |
| Giadinis, N | 1 |
| Kaldrymidou, E | 1 |
| Georgiadis, M | 1 |
| Karatzias, H | 1 |
| Aubert, J | 1 |
| Begriche, K | 1 |
| Delannoy, M | 1 |
| Morel, I | 1 |
| Pajaud, J | 1 |
| Ribault, C | 1 |
| Lepage, S | 1 |
| McGill, MR | 1 |
| Lucas-Clerc, C | 1 |
| Turlin, B | 1 |
| Robin, MA | 1 |
| Jaeschke, H | 1 |
| Fromenty, B | 1 |
| Chalasani, N | 1 |
| Gorski, JC | 1 |
| Asghar, MS | 1 |
| Asghar, A | 1 |
| Foresman, B | 1 |
| Hall, SD | 1 |
| Crabb, DW | 2 |
| Van Winden, SC | 1 |
| Jorritsma, R | 3 |
| Müller, KE | 1 |
| Noordhuizen, JP | 1 |
| Murondoti, A | 2 |
| Beynen, AC | 2 |
| Wensing, T | 4 |
| Geelen, MJ | 2 |
| Tedesco, D | 1 |
| Tava, A | 1 |
| Galletti, S | 1 |
| Tameni, M | 1 |
| Varisco, G | 1 |
| Costa, A | 1 |
| Steidler, S | 1 |
| Adams, LA | 1 |
| Angulo, P | 1 |
| Sanyal, AJ | 1 |
| Mofrad, PS | 1 |
| Contos, MJ | 1 |
| Sargeant, C | 1 |
| Luketic, VA | 1 |
| Sterling, RK | 1 |
| Stravitz, RT | 1 |
| Shiffman, ML | 1 |
| Clore, J | 1 |
| Mills, AS | 1 |
| Bugianesi, E | 1 |
| Gastaldelli, A | 1 |
| Vanni, E | 1 |
| Gambino, R | 1 |
| Cassader, M | 1 |
| Baldi, S | 1 |
| Ponti, V | 1 |
| Pagano, G | 1 |
| Ferrannini, E | 1 |
| Rizzetto, M | 1 |
| You, M | 1 |
| Considine, RV | 1 |
| Leone, TC | 1 |
| Kelly, DP | 1 |
| Waldron, MR | 1 |
| Kulick, AE | 1 |
| Bell, AW | 1 |
| Overton, TR | 1 |
| Gauthier, MS | 1 |
| Favier, R | 1 |
| Lavoie, JM | 1 |
| Cooke, RF | 1 |
| Silva Del Río, N | 1 |
| Caraviello, DZ | 1 |
| Bertics, SJ | 3 |
| Ramos, MH | 1 |
| Grummer, RR | 3 |
| Reid, BN | 1 |
| Otlivanchik, OA | 1 |
| Schoiswohl, G | 1 |
| Zechner, R | 1 |
| Blaner, WS | 1 |
| Goldberg, IJ | 1 |
| Schwabe, RF | 1 |
| Chua, SC | 1 |
| Huang, LS | 1 |
| Knapp, AC | 1 |
| Todesco, L | 1 |
| Torok, M | 1 |
| Beier, K | 1 |
| Krähenbühl, S | 1 |
| Gröhn, Y | 1 |
| Lindberg, LA | 1 |
| Bruss, ML | 1 |
| Farver, TB | 1 |
| Gaal, T | 1 |
| Roberts, CJ | 1 |
| Reid, IM | 1 |
| Dew, AM | 1 |
| Copp, CM | 1 |
| Studer, VA | 1 |
| Reynolds, CK | 1 |
| Maisey, I | 1 |
| Andrews, AH | 2 |
| Laven, RA | 2 |
| Mudron, P | 1 |
| Rehage, J | 1 |
| Sallmann, HP | 1 |
| Mertens, M | 1 |
| Scholz, H | 1 |
| Kovac, G | 1 |
| Pazak, HE | 1 |
| Bartges, JW | 1 |
| Cornelius, LC | 1 |
| Scott, MA | 1 |
| Gross, K | 1 |
| Huber, TL | 1 |
| Rukkwamsuk, T | 1 |
| Kruip, TA | 2 |
| Meijer, GA | 1 |
| Hippen, AR | 1 |
| She, P | 1 |
| Young, JW | 3 |
| Lindberg, GL | 1 |
| Richardson, LF | 1 |
| Tucker, RW | 1 |
| Zerbe, H | 1 |
| Schneider, N | 1 |
| Leibold, W | 1 |
| Schuberth, HJ | 1 |
| Tornquist, SJ | 1 |
| Cebra, CK | 1 |
| Van Saun, RJ | 1 |
| Smith, BB | 1 |
| Mattoon, JS | 1 |
| Katoh, N | 1 |
| Oikawa, S | 1 |
| Oohashi, T | 1 |
| Takahashi, Y | 1 |
| Itoh, F | 1 |
| Inokuchi, T | 1 |
| Orita, M | 1 |
| Imamura, K | 1 |
| Takao, T | 1 |
| Isogai, S | 1 |
| Cadorniga-Valino, C | 1 |
| Stoddard, EE | 1 |
| Veenhuizen, JJ | 1 |
| Drackley, JK | 2 |
| Richard, MJ | 1 |
| Sanderson, TP | 1 |
| Miller, LD | 1 |
| Kim, YK | 1 |
| Strang, BD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)[NCT00845845] | Phase 2 | 12 participants (Actual) | Interventional | 2006-03-31 | Terminated (stopped due to Terminated due to low enrollment.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for 3-hydroxybutyric acid and Fatty Liver
| Article | Year |
|---|---|
Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Res | 2021 |
Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease.
Topics: 3-Hydroxybutyric Acid; Cannabinoid Receptor Modulators; Catheterization; Deuterium; Endocannabinoids | 2010 |
Chronic metabolic responses of postpartal dairy cows to subcutaneous glucagon injections, oral glycerol, or both.
Topics: 3-Hydroxybutyric Acid; Administration, Oral; Animals; Blood Glucose; Cattle; Cattle Diseases; Drug S | 2010 |
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.
Topics: 3-Hydroxybutyric Acid; Alanine Transaminase; Antioxidants; Drug Therapy, Combination; Fatty Acids, N | 2004 |
Supplemental choline for prevention and alleviation of fatty liver in dairy cattle.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; Choline; Dairying; Dietary S | 2007 |
48 other studies available for 3-hydroxybutyric acid and Fatty Liver
| Article | Year |
|---|---|
Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver.
Topics: 3-Hydroxybutyric Acid; Acetyl Coenzyme A; Animals; Fatty Liver; Liver; Mice; Polychlorinated Dibenzo | 2023 |
Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver.
Topics: 3-Hydroxybutyric Acid; Animals; Cattle; Cattle Diseases; Fatty Acids, Nonesterified; Fatty Liver; Fe | 2023 |
Subnuclear renal tubular vacuoles in alcohol use disorder.
Topics: 3-Hydroxybutyric Acid; Alcoholism; Diabetic Ketoacidosis; Epithelial Cells; Fatty Liver; Forensic Pa | 2023 |
Sirtuin 3 improves fatty acid metabolism in response to high nonesterified fatty acids in calf hepatocytes by modulating gene expression.
Topics: 3-Hydroxybutyric Acid; Acetyl-CoA Carboxylase; Acyl-CoA Oxidase; Animals; Carnitine O-Palmitoyltrans | 2020 |
Effect of Adrenergic Agonists on High-Fat Diet-Induced Hepatic Steatosis in Mice.
Topics: 3-Hydroxybutyric Acid; Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Carn | 2020 |
Impaired hepatic autophagic activity in dairy cows with severe fatty liver is associated with inflammation and reduced liver function.
Topics: 3-Hydroxybutyric Acid; Animals; Autophagosomes; Autophagy; Biomarkers; Blood Glucose; Cattle; Energy | 2018 |
Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly.
Topics: 3-Hydroxybutyric Acid; Animals; Apolipoprotein B-100; Apolipoproteins E; Carrier Proteins; Cattle; C | 2019 |
Low abundance of mitofusin 2 in dairy cows with moderate fatty liver is associated with alterations in hepatic lipid metabolism.
Topics: 3-Hydroxybutyric Acid; Animals; Cattle; Cattle Diseases; Diacylglycerol O-Acyltransferase; Fatty Aci | 2019 |
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Topics: 3-Hydroxybutyric Acid; Animals; Biomarkers; Blood Glucose; Diet; Disease Progression; Fatty Acids; F | 2013 |
Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.
Topics: 3-Hydroxybutyric Acid; Acetate-CoA Ligase; Acetyl-CoA C-Acetyltransferase; Adult; Aged; Biomarkers; | 2015 |
Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency.
Topics: 3-Hydroxybutyric Acid; Animals; Fatty Acids; Fatty Liver; Female; Ketone Bodies; Lipid Peroxidation; | 2015 |
Activation of ERK1/2 Ameliorates Liver Steatosis in Leptin Receptor-Deficient (db/db) Mice via Stimulating ATG7-Dependent Autophagy.
Topics: 3-Hydroxybutyric Acid; Animals; Autophagy; Autophagy-Related Protein 7; Enzyme Activation; Fatty Liv | 2016 |
Obesity-driven prepartal hepatic lipid accumulation in dairy cows is associated with increased CD36 and SREBP-1 expression.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; CD36 Antigens; Fatty Acids; | 2016 |
Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Case-Control Studies; Cystathionine; Fasting; Fat Emulsions, Int | 2009 |
Liver fat and lipid oxidation in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Energy Metabolism; Fatty Acids, Nonesterified; Fatty Liver; Female; Hu | 2009 |
Lecithin cholesterol acyltransferase (LCAT) activity as a predictor for ketosis and parturient haemoglobinuria in Egyptian water buffaloes.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Blood Proteins; Buffaloes; Cholesterol; Fatty Acids, | 2010 |
Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?
Topics: 3-Hydroxybutyric Acid; Adult; Alanine Transaminase; Apolipoproteins B; Area Under Curve; C-Reactive | 2010 |
Clinicopathological evaluation of downer dairy cows with fatty liver.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Bilirubin; Carboxyl and Carbamoyl Transferases; Cattl | 2010 |
Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.
Topics: 3-Hydroxybutyric Acid; 8-Hydroxy-2'-Deoxyguanosine; Adult; Alanine Transaminase; Bile Acids and Salt | 2011 |
Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice.
Topics: 3-Hydroxybutyric Acid; Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cytochrome P- | 2012 |
Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Body Mass Index; Chlorzoxazone; Cholesterol, HDL; Cytoc | 2003 |
Feed intake, milk yield, and metabolic parameters prior to left displaced abomasum in dairy cows.
Topics: 3-Hydroxybutyric Acid; Abomasum; Animals; Aspartate Aminotransferases; Blood Glucose; Calcium; Cattl | 2003 |
Activities of the enzymes of hepatic gluconeogenesis in periparturient dairy cows with induced fatty liver.
Topics: 3-Hydroxybutyric Acid; Animals; Cattle; Fatty Acids, Nonesterified; Fatty Liver; Female; Food Depriv | 2004 |
Unrestricted feed intake during the dry period impairs the postpartum oxidation and synthesis of fatty acids in the liver of dairy cows.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; 3-Hydroxybutyric Acid; Acetyl-CoA Carboxylase; Adipose Tissue; Ani | 2004 |
Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows.
Topics: 3-Hydroxybutyric Acid; Animals; Body Composition; Cattle; Cattle Diseases; Colostrum; Drug Residues; | 2004 |
Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
Topics: 3-Hydroxybutyric Acid; Alanine Transaminase; Antioxidants; Drug Therapy, Combination; Fatty Acids, N | 2004 |
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Blood Glucose; Body Composition; C-Peptide; Calorimetr | 2005 |
Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.
Topics: 3-Hydroxybutyric Acid; Acetyl-CoA Carboxylase; Adiponectin; Animals; Cholesterol; Dietary Fats; Dise | 2005 |
Acute experimental mastitis is not causal toward the development of energy-related metabolic disorders in early postpartum dairy cows.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; Diet; Energy Metabolism; Esc | 2006 |
Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Animals; Diet; Dietary Fats; Energy Intake; Fatty Acids, None | 2006 |
Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Animals; Apolipoproteins B; Carboxylic Ester Hydrolases; Cell | 2008 |
Effect of carnitine deprivation on carnitine homeostasis and energy metabolism in mice with systemic carnitine deficiency.
Topics: 3-Hydroxybutyric Acid; Adenosine Triphosphate; Animals; Body Weight; Carnitine; Energy Metabolism; F | 2008 |
Fatty infiltration of liver in spontaneously ketotic dairy cows.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acidosis; Animals; Biopsy, Needle; Blood Glucose; Cattle; Catt | 1983 |
Blood composition and liver fat in post parturient dairy cows.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; Circadian Rhythm; Dairying; | 1983 |
Effect of prepartum propylene glycol administration on periparturient fatty liver in dairy cows.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; Fatty Acids, Nonesterified; | 1993 |
Efficacy of recombinant bovine somatotrophin in the treatment of fat cow syndrome.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Blood Proteins; Cattle; Cattle Diseases; Fatty Liver; | 1993 |
Plasma and liver alpha-tocopherol in dairy cows with left abomasal displacement and fatty liver.
Topics: 3-Hydroxybutyric Acid; Abomasum; Animals; Blood Glucose; Cattle; Cattle Diseases; Fatty Acids, Nones | 1997 |
Control of fatty liver syndrome in a Jersey herd by a change of diet and the use of recombinant bovine somatotrophin.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; Fatty Liver; Female; Growth | 1998 |
Characterization of serum lipoprotein profiles of healthy, adult cats and idiopathic feline hepatic lipidosis patients.
Topics: 3-Hydroxybutyric Acid; Animals; Cat Diseases; Cats; Cholesterol; Fatty Acids, Nonesterified; Fatty L | 1998 |
Hepatic fatty acid composition in periparturient dairy cows with fatty liver induced by intake of a high energy diet in the dry period.
Topics: 3-Hydroxybutyric Acid; Animals; Cattle; Cattle Diseases; Energy Intake; Fatty Acids; Fatty Acids, No | 1999 |
Alleviation of fatty liver in dairy cows with 14-day intravenous infusions of glucagon.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Composition; Cattle; Cattle Diseases; Fatty Acid | 1999 |
Altered functional and immunophenotypical properties of neutrophilic granulocytes in postpartum cows associated with fatty liver.
Topics: 3-Hydroxybutyric Acid; Animals; Antibodies, Monoclonal; Biopsy; Cattle; Cattle Diseases; Fatty Acids | 2000 |
Metabolic changes and induction of hepatic lipidosis during feed restriction in llamas.
Topics: 3-Hydroxybutyric Acid; Animals; Aspartate Aminotransferases; Bile Acids and Salts; Biopsy, Needle; C | 2001 |
Decreases of apolipoprotein B-100 and A-I concentrations and induction of haptoglobin and serum amyloid A in nonfed calves.
Topics: 3-Hydroxybutyric Acid; Animals; Apolipoprotein B-100; Apolipoproteins; Apolipoproteins B; Cattle; Ca | 2002 |
Resistance to ketosis in moderately obese patients: influence of fatty liver.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Fatty Liver; F | 1992 |
Effect of prepartum dry matter intake on liver triglyceride concentration and early lactation.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; Eating; Fatty Acids, Noneste | 1992 |
Metabolic changes in blood and liver during development and early treatment of experimental fatty liver and ketosis in cows.
Topics: 3-Hydroxybutyric Acid; Acetates; Animals; Blood Glucose; Body Weight; Cattle; Cattle Diseases; Eatin | 1991 |
Metabolic responses of lactating goats to feed restriction and dietary 1,3-butanediol.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Weight; Butylene Glycols; Cattle; Cattle Disease | 1989 |